Device Trial Radar · NCT06547138
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
110
Planned (sponsor's estimate)
Start
Feb 2027
Primary completion
Mar 2028
Study completion Sep 2029
Sponsor
- Lead sponsor
- Aesculap AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- B.Braun Surgical SA
- First posted
- Aug 9, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.
Conditions
- Abdominal Aortic Aneurysm
- Morbid Obesity
Interventions
Prophylactic meshDevice
Prevention of incisional hernia after a prophylactic mesh in high-risk patients
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical Site Infection (SSI) A2/A3 rateTime frame: at 6 months follow-up
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Hospital Universitari Germans Tries i Pujol
Badalona, Spain
Hospital Municipal Badalona
Badalona, Spain
Hospital Comarcal Sant Jaume de Calella
Calella, Spain
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.